Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business [Reuters]
Biogen Inc. (BIIB)
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
biogen.com/en_us/investors.html
Company Research
Source: Reuters
Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business | Reuters 2 Min Read TOKYO (Reuters) - Japan’s Fujifilm Holdings Corp will buy a drugmaking business from U.S.-based Biogen Inc for about $890 million to try to bolster its healthcare business as growth at its legacy photocopy operations stagnates. The unit holds Biogen’s biologics manufacturing operations in HillerA¸d, Denmark and about 800 employees at the subsidiary are expected to continue employment under Fujifilm, Biogen said in a statement on Tuesday. Fujifilm, known for its photocopier and imaging products, has been slowly expanding into healthcare. Last year the company said it would buy two biotechnology units from compatriot JXTG Holdings Inc for about $800 million. While imaging and healthcare brought in nearly the same amount of revenue for the nine months until December, the latter grew at a much faster pace. It recorded 11 percent year-on-year growth in that period while the imaging service po
Show less
Read more
Impact Snapshot
Event Time:
BIIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
News
- Should You Be Confident in Biogen (BIIB)? [Yahoo! Finance]Yahoo! Finance
- What's in Store for Biogen (BIIB) This Earnings Season? [Yahoo! Finance]Yahoo! Finance
- Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $290.00 to $270.00. They now have an "outperform" rating on the stock.MarketBeat
- Alzheimer's Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
BIIB
Earnings
- 2/14/24 - Miss
BIIB
Sec Filings
- 4/24/24 - Form 8-K
- 4/12/24 - Form PRE
- 4/3/24 - Form 4
- BIIB's page on the SEC website